RxDoctor Payments Data

Robert Keller, MD

Otolaryngology · Colorado Springs, CONPI 1154760866

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,271 of the $45,009 with a category attached, or 85.0%. Sanofi accounts for 75.7% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $17,610, more than ten times the $476 reported in 2019. Among otolaryngology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,009in general payments, 2019–2025

Across 143 payments — averaging $314.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$34K
  • Regeneron Healthcare Solutions, Inc.$8K
  • Stryker$1K
  • AstraZeneca$572
  • Medtronic$383
  • GSK$263
  • plus $789 from 14 others

What the payments were for

  • Consulting fees$1,5443%
  • Speaking & faculty fees$38,27185%
  • Travel & lodging$1,3893%
  • Food & beverage$3,7918%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,009 in reported general payments places this provider in the 95th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$306,385
Medicare patients
493
Services billed
1,659

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide140$3,350
Fluticasone Propionate159$3,199
Pantoprazole Sodium166$2,199
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav61$977
Azelastine Hcl31$730
Mupirocin53$489
Fluocinolone Acetonide Oil12$425
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen74$327
Methylprednisolone29$215
Ofloxacin13$194
Dexamethasone42$185
Doxycycline Hyclate15$176
Famotidine19$145
Triazolam13$90
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$69

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →